Stockreport

Definium Therapeutics Teases 3 Key DT-120 Data Readouts This Year, Highlights De-Risked Phase 3 Design [Yahoo! Finance]

Joby Aviation, Inc.  (JOBY) 
PDF its lead psychedelic-derived program during a management discussion, emphasizing multiple pivotal readouts expected later this year and a focus on trial design intended [Read more]